Company Filing History:
2 out of 188 
2 out of 523 
1 out of 4,455 
Years Active: 2005-2014
Title: Mark Peter Warchol: Innovator in Pharmaceutical Formulations
Introduction
Mark Peter Warchol is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the administration of nicotine for therapeutic purposes. With a total of 5 patents to his name, Warchol's work focuses on innovative methods to aid in the treatment of tobacco addiction.
Latest Patents
Warchol's latest patents include formulations that provide liquid pharmaceutical solutions comprising nicotine for administration primarily to the lungs. These formulations are designed to be acidified and/or alkalized through buffering and/or pH regulation, allowing for a rapid increase of nicotine levels in the arterial blood of a subject after administration. The preferred method of administration involves spraying an aerosol into the oral cavity, facilitating further distribution into the lungs. Additionally, methods for manufacturing these formulations are disclosed, along with their therapeutic uses, particularly in treating tobacco addiction.
Career Highlights
Throughout his career, Warchol has worked with prominent companies such as McNeil AB and Pharmacia & Upjohn Company. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Warchol has collaborated with notable individuals in his field, including Michael John Hawley and Walter Morozowich. These partnerships have likely enhanced his research and development efforts in creating effective pharmaceutical solutions.
Conclusion
Mark Peter Warchol stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of nicotine formulations for therapeutic use. His innovative approaches and collaborations have the potential to significantly impact the treatment of tobacco addiction.